Pulse 2.0 reported on LucyRx and Abarca Health’s strategic combination to create a modern, independent PBM designed to serve commercial and government clients at scale. The article outlines the market forces behind the announcement, including increased PBM scrutiny, rising pressure from high-cost specialty drugs and GLP-1s, and growing demand for more flexible, accountable and affordable pharmacy benefit models.
The coverage also underscores the practical pieces of the combination: Abarca’s Darwin Healthcare Intelligence platform and government program expertise, paired with LucyRx’s clinical capabilities, employer-market presence and Connected Specialty Care Network. It reinforces that clients and members are expected to experience no disruption, with day-to-day operations, account relationships, responsiveness and service standards continuing under the same teams.
Share